Details of the Drug

General Information of Drug (ID: DMQG9OI)

Drug Name

SB-509

Synonyms

ALS therapy, Sangamo; Diabetic neuropathy therapy, Sangamo; AdV-ZFP-VEGF; VEGF ZFP TF, Sangamo-2; VEGF activation, Sangamo-2

Indication

Disease Entry	ICD 11	Status	REF
Nervous system disease	8A00-8E7Z	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01079325) Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy. U.S. National Institutes of Health.